Skip to main content

Table 4 Descriptive, treatment and intermediate outcome measures by ethnic group

From: Ethnic inequalities in the treatment and outcome of diabetes in three English Primary Care Trusts

  Ethnic Group N (%)  
  White South Asian Black African/Afro-Caribbean Other Not recorded p-value*
Descriptive Measures
Mean Age 65.4 59.7 62.8 58.9 61.8 p < 0.001
Median (IQR) (54.2–74.4) (50.2–67.6) (52.3–69.4) (49.4–67.9) (49.2–71.7)  
Sex N (%)       
Male 3463 (55.4) 3140 (56.6) 778 (45.9) 750 (53.7) 3507 (54.4) p < 0.001
Female 2775 (44.4) 2381 (42.9) 913 (53.8) 638 (45.7) 2900 (45.0)  
Not recorded 15 (0.2) 30 (0.5) 6 (0.4) 9 (0.6) 38 (0.6)  
Mean BMI 28.7 27 28.5 27.3 27.3 p < 0.001
Median(IQR) (25.2–33.0) (24.3–30.4) (25.5–32.2) (24.6–31.1) (24.2–31.2)  
Not recorded N(%) 870(13.9) 495(8.9) 233 (13.73) 195 (14.0) 2361(36.6)  
Smoker N(%) 1152 (18.4) 389 (7.0) 190 (11.2) 179 (12.8) 822 (12.8) p < 0.001
Not recorded 281 (4.5) 430 (7.8) 82 (4.8) 94 (6.7) 1508 (23.4) p < 0.001
Treatment Measures
On insulin N (%) 443 (7.1) 263 (4.7) 126 (7.4) 80 (5.7) 592 (9.2) p < 0.001
On statins N (%) 1860 (29.8) 1744 (31.4) 425 (25.0) 399 (28.6) 1405 (21.8) p < 0.001
Intermediate Outcome Measures
HbA1c < 7.4 N (%) 2368 (37.9) 1423 (25.6) 540 (31.8) 438 (31.4) 1354 (21.0) p < 0.001
Not recorded 1100 (17.6) 1377 (24.8) 313 (18.4) 320 (22.9) 3248 (50.4)  
BP < = 145 N (%) 4094 (65.5) 3711 (66.9) 1095 (64.5) 995 (71.2) 3604 (55.9) p < 0.001
Not recorded 119 (1.9) 57 (1.0) 21 (1.2) 32 (2.3) 1035 (16.1)  
Cholesterol < = 5 N(%) 2537 (40.6) 2275 (41.0) 711 (41.9) 580 (41.5) 1609 (25.0) 0.038
Not recorded 1056 (16.9) 1154 (20.8) 265 (15.6) 226 (16.2) 2953 (45.8) p < 0.001
  1. * note that the Chi-square tests for care process and intermediate outcome measures exclude the missing value category